Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response
James J. Knox, Marcus Buggert, Lela Kardava, Kelly E. Seaton, Michael A. Eller, David H. Canaday, Merlin L. Robb, Mario A. Ostrowski, Steven G. Deeks, Mark K. Slifka, Georgia D. Tomaras, Susan Moir, M. Anthony Moody, Michael R. Betts
James J. Knox, Marcus Buggert, Lela Kardava, Kelly E. Seaton, Michael A. Eller, David H. Canaday, Merlin L. Robb, Mario A. Ostrowski, Steven G. Deeks, Mark K. Slifka, Georgia D. Tomaras, Susan Moir, M. Anthony Moody, Michael R. Betts
View: Text | PDF
Research Article AIDS/HIV Immunology

T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response

  • Text
  • PDF
Abstract

Humoral immunity is critical for viral control, but the identity and mechanisms regulating human antiviral B cells are unclear. Here, we characterized human B cells expressing T-bet and analyzed their dynamics during viral infections. T-bet+ B cells demonstrated an activated phenotype, a distinct transcriptional profile, and were enriched for expression of the antiviral immunoglobulin isotypes IgG1 and IgG3. T-bet+ B cells expanded following yellow fever virus and vaccinia virus vaccinations and also during early acute HIV infection. Viremic HIV-infected individuals maintained a large T-bet+ B cell population during chronic infection that was associated with increased serum and cell-associated IgG1 and IgG3 expression. The HIV gp140–specific B cell response was dominated by T-bet–expressing memory B cells, and we observed a concomitant biasing of gp140-specific serum immunoglobulin to the IgG1 isotype. These findings suggest that T-bet induction promotes antiviral immunoglobulin isotype switching and development of a distinct T-bet+ B cell subset that is maintained by viremia and coordinates the HIV Env–specific humoral response.

Authors

James J. Knox, Marcus Buggert, Lela Kardava, Kelly E. Seaton, Michael A. Eller, David H. Canaday, Merlin L. Robb, Mario A. Ostrowski, Steven G. Deeks, Mark K. Slifka, Georgia D. Tomaras, Susan Moir, M. Anthony Moody, Michael R. Betts

×

Figure 1

T-bet expression in memory B cell subsets from healthy human peripheral blood.

Options: View larger image (or click on image) Download as PowerPoint
T-bet expression in memory B cell subsets from healthy human peripheral ...
(A) Representative flow cytometry plots of T-bet expression in peripheral blood B cell subsets from a single donor. (B) T-bet expression frequency per subset in a 10-donor cohort. Bars on this and all following plots represent mean ± SEM. Trans., transitional B cell.(C) T-bet expression frequency of memory B cells expressing different Ig isotypes. (D) CD21/CD27–based gating scheme of total CD38loCD10– B cells from a representative donor. AM, activating memory, CD27+CD21–; RM, resting memory, CD27+CD21+; TLM, tissue-like memory, CD27–CD21–. (E) T-bet expression frequency of CD21/CD27–derived B cell subsets. (F) T-bet median fluorescence intensity (MFI) of T-bet+ cells from each B cell subset. (G) Gating of CD21–CD85jhi and CD21–CD85jlo B cell subsets from a representative donor’s total CD38loCD10– B cells. (H) T-bet expression histogram of CD85j-gated B cell subsets from donor depicted in G. (I) T-bet expression frequency of CD85j-gated B cell subsets in 10-donor cohort. (J) Expression frequency of homing receptors (CD11c, CXCR3), activation markers (CD69, CD71, CD86, CD95), and inhibitory receptors (PD-1, FcRL4/5) by CD38loCD10– B cell subsets. Statistical comparisons in B, C, E, F, and J calculated using repeated-measures 1-way ANOVA with Tukey’s multiple comparisons test. Statistical comparison in I calculated using paired t test. *P ≥ 0.01 to < 0.05; **P ≥ 0.001 to < 0.01; ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts